Specialist Updates 
Oncology

Liquid biopsy can ‘personalise’ therapy for colon cancer

A randomised trial in Australia shows use of the test reduces adjuvant chemotherapy without increasing cancer recurrence
0
20 June 2022
Save

A liquid biopsy-guided approach to treating stage II colon cancer can reduce reliance on adjuvant chemotherapy without jeopardising patient survival, a pivotal study suggests.

Melbourne-led authors say results from the DYNAMIC trial could further personalise oncological care, with the decision to treat predicated on presence of circulating tumour DNA (ctDNA).

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .